COVID-19

Initiated by UAE - First online professional symposium with Israeli CEO of the MIGAL Institute

07-09-2020
TRENDS Research and Advisory
Initiated by UAE - First online professional symposium with Israeli CEO of the MIGAL Institute

Initiated by the UAE - First online professional symposium with the participation of an Israeli, CEO of the MIGAL Institute, and other global experts to develop a COVID-19 vaccine

By Dana Elimelech

Researchers from the MIGAL Institute use the Oracle Cloud as part of their fight against COVID-19

14-09-2020
SoftNews
Researchers from the MIGAL Institute use the Oracle Cloud as part of their fight against COVID-19

The MIGAL Galilee Research Institute, which is developing a vaccine for the novel coronavirus via its subsidiary MigVax, uses the Oracle Cloud Infrastructure to support its research efforts as part of the global mobilization to combat COVID-19. As part of the development process, the researchers have been analyzing huge databases of viral genetic sequences in order to identify the virus’s weaknesses.

Researchers
Research Groups

WARNING!! Fraud Notice – Covid-19 Product

26-05-2020
Migal Galilee Research Institute Ltd., Migvax Ltd.
WARNING!! Fraud Notice – Covid-19 Product
We have just been made aware that a fake pharmaceutical product allegedly for use in connection with COVID-19 is fraudulently being advertised and apparently sold in South America with the logo of Migal and with the following wording: " COVID-19 vaccine tracker. Cutting edge Israeli Biotech innovating coronavirus immunotherapy treatments." A photograph appears below.  

Breakthrough from Israel’s MIGAL Research Institute in Development of Corona virus (COVID-19) Vaccine

27-02-2020
Israel’s Ministry of Science & Technology
Breakthrough from Israel’s MIGAL Research Institute in Development of Corona virus (COVID-19) Vaccine
After four years of research funded by Israel’s Ministry of Science & Technology, MIGAL’s researchers have developed an effective vaccine against avian coronavirus Infectious Bronchitis Virus (IBV), to be adapted soon and create a human vaccine against COVID-19 
Researchers

COVIS-19Coronavírus: vacina pode ser criada em 90 dias, diz instituto de Israel

19-03-2020
Por Márcio Juliboni
COVIS-19Coronavírus: vacina pode ser criada em 90 dias, diz instituto de Israel
Contra o tempo: cientistas israelenses afirmam estar perto de obter vacina contra o coronavírus (Imagem: Unsplash/@cdc) Uma vacina contra o coronavírus pode ser criada em 90 dias. A afirmação foi feita por David Zigdon, CEO do Galilee Research Institute (Migal), localizado na Galileia, em Israel. Zigdon participou de uma entrevista coletiva nesta quinta-feira (27), junto com sua equipe, para anunciar avanços nas pesquisas.